NeuroGenesis announces positive data from multiple sclerosis trial
Clinical Trials Arena - 13 Mar 2024NeuroGenesis Bio has reported positive outcomes from an interim analysis during the open-label extension of a Phase II clinical trial for NG-01 in treating ...